These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 32025275)

  • 1. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis.
    Zhou H; Zhu X
    Cancer Manag Res; 2019; 11():2039-2050. PubMed ID: 30881128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
    Jiang JX; Zhang N; Liu ZM; Wang YY
    Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
    Wu B; Zhen K; Guo L; Sun C
    Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating Non-coding RNAs as Potential Biomarkers for Ischemic Stroke: A Systematic Review.
    Zhao J; Wang Q; Zhu R; Yang J
    J Mol Neurosci; 2022 Aug; 72(8):1572-1585. PubMed ID: 35380333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer.
    Yi M; Liao Z; Deng L; Xu L; Tan Y; Liu K; Chen Z; Zhang Y
    Ann Med; 2021 Dec; 53(1):2178-2193. PubMed ID: 34913774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of DWI in patients with ovarian cancer: A meta-analysis.
    Yuan X; Guo L; Du W; Mo F; Liu M
    Medicine (Baltimore); 2017 May; 96(19):e6659. PubMed ID: 28489739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
    Wu Q; Bai SN; Song LY; Wu WF; Han LN
    Medicine (Baltimore); 2023 Aug; 102(33):e34737. PubMed ID: 37603503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
    Guo Z; Zhao C; Wang Z
    Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-17 family as novel biomarkers for cancer diagnosis: a meta-analysis based on 19 articles.
    Gu R; Huang S; Huang W; Li Y; Liu H; Yang L; Huang Z
    Tumour Biol; 2016 May; 37(5):6403-11. PubMed ID: 26631037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
    Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysis.
    Qiu L; Weng G
    J Ovarian Res; 2022 May; 15(1):51. PubMed ID: 35501921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
    Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
    BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
    Lin JY; Qin JB; Li XY; Dong P; Yin BD
    Asian Pac J Cancer Prev; 2012; 13(11):5427-32. PubMed ID: 23317195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
    Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
    Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
    Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
    Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.